MedinCell S.A.
MDCLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $188 | $185 | $225 | $218 |
| - Cash | $59 | $19 | $6 | $25 |
| + Debt | $59 | $59 | $58 | $47 |
| Enterprise Value | $187 | $224 | $277 | $241 |
| Revenue | $26 | $9 | $10 | $4 |
| % Growth | 178.8% | -7.9% | 143.1% | – |
| Gross Profit | $26 | $9 | $10 | $4 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$11 | -$19 | -$26 | -$21 |
| % Margin | -43.9% | -203.2% | -265.6% | -524.4% |
| Net Income | -$18 | -$25 | -$32 | -$25 |
| % Margin | -72.2% | -273.3% | -321.9% | -606.5% |
| EPS Diluted | -0.63 | -0.88 | -1.27 | -1 |
| % Growth | 28.4% | 30.7% | -27% | – |
| Operating Cash Flow | $19 | -$12 | -$21 | -$21 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$2 |
| Free Cash Flow | $18 | -$13 | -$22 | -$23 |